Time-series transcriptional profiling yields new perspectives on susceptibility to murine osteoarthritis.

OBJECTIVE Chronological age is a powerful epidemiologic risk factor for osteoarthritis (OA), a multifactorial disease that is characterized by articular cartilage (AC) degradation. It is unclear from a molecular perspective how aging interacts with OA to produce this risk to AC integrity. To address this key question, we used in vivo time-course analysis of OA development and murine interstrain variability in natural susceptibility to OA to examine changes in non-OA-prone CBA mice versus OA-prone STR/Ort mice, which develop disease that bears significant histologic resemblance to human OA. Through global transcriptome profiling, we attempted to discover the molecular signature linked with both OA vulnerability and progression. METHODS Affymetrix Mouse Gene 1.0 ST Array profiles were generated from AC samples derived from CBA and STR/Ort mice at 3 different ages, corresponding to the stages prior to, at, and late after the natural onset of OA in the STR/Ort mice. RESULTS We found that the OA in STR/Ort mice exhibited a molecular phenotype resembling human OA, and we pinpointed a central role of NF-κB signaling and the emergence of an immune-related signature in OA cartilage over time. We discovered that, strikingly, young healthy AC has a highly expressed skeletal muscle gene expression program, which is switched off during maturation, but is intriguingly retained in AC during OA development in STR/Ort mice. CONCLUSION This study is the first to show that AC chondrocytes share a high-abundance gene-expression program with skeletal muscle. We show that failure to switch this program off, as well as the restoration of this program, is associated with inappropriate expression of NF-κB signaling pathways, skeletal muscle-related genes, and induction and/or progression of OA.

[1]  Amy L. Olex,et al.  Microarray analysis reveals age-related differences in gene expression during the development of osteoarthritis in mice. , 2012, Arthritis and rheumatism.

[2]  A. Pitsillides,et al.  Cartilage biology in osteoarthritis—lessons from developmental biology , 2011, Nature Reviews Rheumatology.

[3]  J. Loughlin Genetics of osteoarthritis , 2011, Current opinion in rheumatology.

[4]  J. Pelletier,et al.  Peroxisome proliferator-activated receptor gamma in osteoarthritis , 2011, Modern rheumatology.

[5]  R. L. Cain,et al.  Analysis of early changes in the articular cartilage transcriptisome in the rat meniscal tear model of osteoarthritis: pathway comparisons with the rat anterior cruciate transection model and with human osteoarthritic cartilage. , 2010, Osteoarthritis and cartilage.

[6]  Claude Bouchard,et al.  Using molecular classification to predict gains in maximal aerobic capacity following endurance exercise training in humans. , 2010, Journal of applied physiology.

[7]  R. Schulz,et al.  Biomechanical modulation of collagen fragment-induced anabolic and catabolic activities in chondrocyte/agarose constructs , 2010, Arthritis research & therapy.

[8]  M. Goldring,et al.  NF-kappaB signaling: multiple angles to target OA. , 2010, Current drug targets.

[9]  Z. Werb,et al.  Matrix metalloproteinase 13-deficient mice are resistant to osteoarthritic cartilage erosion but not chondrocyte hypertrophy or osteophyte development. , 2009, Arthritis and rheumatism.

[10]  Jie Huang,et al.  The IκBα gene is a peroxisome proliferator‐activated receptor cardiac target gene , 2009, The FEBS journal.

[11]  M. Goldring,et al.  Cartilage homeostasis in health and rheumatic diseases , 2009, Arthritis research & therapy.

[12]  T. Underhill,et al.  The retinoic acid binding protein CRABP2 is increased in murine models of degenerative joint disease , 2009, Arthritis research & therapy.

[13]  C. Brew,et al.  Gene expression in human chondrocytes in late osteoarthritis is changed in both fibrillated and intact cartilage without evidence of generalised chondrocyte hypertrophy , 2008, Annals of the rheumatic diseases.

[14]  M. Goldring,et al.  Defining the roles of inflammatory and anabolic cytokines in cartilage metabolism , 2008, Annals of the rheumatic diseases.

[15]  J. Saklatvala,et al.  Is the response of cartilage to injury relevant to osteoarthritis? , 2008, Arthritis and rheumatism.

[16]  F. Dell’Accio,et al.  Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. , 2008, Arthritis and rheumatism.

[17]  R. Dinser Animal models for arthritis. , 2008, Best practice & research. Clinical rheumatology.

[18]  Xin Fu,et al.  Suppression of early experimental osteoarthritis by in vivo delivery of the adenoviral vector-mediated NF-kappaBp65-specific siRNA. , 2008, Osteoarthritis and cartilage.

[19]  Robert L. Phillips,et al.  Inverse relationship between matrix remodeling and lipid metabolism during osteoarthritis progression in the STR/Ort mouse. , 2007, Arthritis and rheumatism.

[20]  L. Sandell Modern molecular analysis of a traditional disease: progression in osteoarthritis. , 2007, Arthritis and rheumatism.

[21]  J. Pelletier,et al.  The peroxisome proliferator-activated receptor gamma agonist pioglitazone reduces the development of cartilage lesions in an experimental dog model of osteoarthritis: in vivo protective effects mediated through the inhibition of key signaling and catabolic pathways. , 2007, Arthritis and rheumatism.

[22]  F. Beier,et al.  Global analyses of gene expression in early experimental osteoarthritis. , 2007, Arthritis and rheumatism.

[23]  Jan Nedergaard,et al.  Myogenic gene expression signature establishes that brown and white adipocytes originate from distinct cell lineages , 2007, Proceedings of the National Academy of Sciences.

[24]  T. Nakahata,et al.  Isolation and characterization of bone marrow-derived mesenchymal progenitor cells with myogenic and neuronal properties. , 2007, Experimental cell research.

[25]  Alexander Zien,et al.  Large-scale gene expression profiling reveals major pathogenetic pathways of cartilage degeneration in osteoarthritis. , 2006, Arthritis and rheumatism.

[26]  P. Roughley,et al.  Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage. , 2006, Matrix biology : journal of the International Society for Matrix Biology.

[27]  I. Singh,et al.  IL-4-Induced Peroxisome Proliferator-Activated Receptor γ Activation Inhibits NF-κB Trans Activation in Central Nervous System (CNS) Glial Cells and Protects Oligodendrocyte Progenitors under Neuroinflammatory Disease Conditions: Implication for CNS-Demyelinating Diseases1 , 2006, The Journal of Immunology.

[28]  S. Yamasaki,et al.  Comparative analysis of gene expression profiles in intact and damaged regions of human osteoarthritic cartilage. , 2006, Arthritis and rheumatism.

[29]  J. Deschner,et al.  Role of NF-kappaB transcription factors in antiinflammatory and proinflammatory actions of mechanical signals. , 2004, Arthritis and rheumatism.

[30]  M. Lotz,et al.  Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. , 2004, Arthritis and rheumatism.

[31]  R. Mason,et al.  Metalloproteinase and tissue inhibitor of metalloproteinase expression in the murine STR/ort model of osteoarthritis. , 2002, Osteoarthritis and cartilage.

[32]  M. Ritter,et al.  Somatostatin is expressed in the murine thymus and enhances thymocyte development , 2002, European journal of immunology.

[33]  R. Mason,et al.  Comparison of collagenase-cleaved articular cartilage collagen in mice in the naturally occurring STR/ort model of osteoarthritis and in collagen-induced arthritis. , 2002, Osteoarthritis and cartilage.

[34]  A Zien,et al.  Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. , 2001, Arthritis and rheumatism.

[35]  R. Mason,et al.  Matrix metalloproteinases and aggrecanases cleave aggrecan in different zones of normal cartilage but colocalize in the development of osteoarthritic lesions in STR/ort mice. , 2001, Arthritis and rheumatism.

[36]  Christine Brun,et al.  In silico prediction of protein-protein interactions in human macrophages , 2001, BMC Research Notes.

[37]  R. Mason,et al.  The STR/ort mouse and its use as a model of osteoarthritis. , 2001, Osteoarthritis and cartilage.

[38]  Frederick Albert Matsen IV,et al.  Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. , 1999, Arthritis and rheumatism.

[39]  E. J. Lewis,et al.  Ro 32-3555, an orally active collagenase selective inhibitor, prevents structural damage in the STR/ORT mouse model of osteoarthritis. , 1998, Arthritis and rheumatism.

[40]  R. Mason,et al.  Chondrocyte cytokine and growth factor expression in murine osteoarthritis. , 1997, Osteoarthritis and cartilage.

[41]  R. Mason,et al.  Elevated aggrecan mRNA in early murine osteoarthritis. , 1997, Osteoarthritis and cartilage.

[42]  R. Mason,et al.  Articular cartilage proteoglycans in osteoarthritic STR/Ort mice. , 1995, Osteoarthritis and cartilage.

[43]  M. Walton Degenerative joint disease in the mouse knee; histological observations , 1977, The Journal of pathology.

[44]  M. Walton Degenerative joint disease in the mouse knee; radiological and morphological observations , 1977, The Journal of pathology.

[45]  K. Mark,et al.  Immunological and biochemical studies of collagen type transition during in vitro chondrogenesis of chick limb mesodermal cells , 1977, The Journal of cell biology.

[46]  L. Crittenden,et al.  The genetics of degenerative joint disease in mice. , 1962, Arthritis and rheumatism.

[47]  L. Sokoloff,et al.  Natural history of degenerative joint disease in small laboratory animals. II. Epiphyseal maturation and osteoarthritis of the knee of mice of inbred strains. , 1956, A.M.A. archives of pathology.

[48]  L. Sokoloff,et al.  Natural history of degenerative joint disease in small laboratory animals. IV. Degenerative joint disease in the laboratory rat. , 1956, A.M.A. archives of pathology.

[49]  A. Pitsillides,et al.  Characterizing a novel and adjustable noninvasive murine joint loading model. , 2011, Arthritis and rheumatism.

[50]  F. Flamigni,et al.  Differential requirements for IKKalpha and IKKbeta in the differentiation of primary human osteoarthritic chondrocytes. , 2008, Arthritis and rheumatism.

[51]  K. Cheah,et al.  Expression of collagen and aggrecan genes in normal and osteoarthritic murine knee joints. , 2002, Osteoarthritis and cartilage.